Delivery Order SPE2DB24D9802-SPE2DB25FJLDZ
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This contract, valued at $3,664.15 with an ultimate completion date of August 6, 2025, carries no set-aside designation and represents a single delivery order under the DLA's broader pharmaceutical supply...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,542.80, is for the delivery of the pharmaceutical product ondansetron hydrochloride. The delivery order has a period of performance through March 3, 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $3,209.86 firm-fixed-price delivery order is for the supply of 4,568,155,855 units of Ondansetron HCL 4 mg tablets. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a wide range of...
- This firm-fixed-price delivery order, valued at $6,397.93, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the supply of pharmaceutical products, including medications such as ondansetron orally disintegrating tablets, to the U.S. Department of Defense (DoD) under the DLA's Medical Supply Chain program. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the Defense Logistics Agency...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $12,021.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,558,233,358 units of Ondansetron HCL 4 mg tablets. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA. The IDC allows the DLA to issue firm...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $1,157.70 for Ondansetron Hydrochloride under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain division. The award, issued on July 28, 2025, with an ultimate completion date of August 7, 2025, represents a discrete ordering action against the company's larger Indefinite Delivery Contract with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,780.34 firm fixed-price delivery order is for the supply of 4560062223 - Ondansetron ODT 4 MG Tablet 30S, with a completion date of February 28, 2023. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued up to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,531.10, is for the delivery of pharmaceutical products, including ondansetron 8mg tablets, to support the medical supply needs of Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,994.48 firm fixed-price delivery order is for the supply of Ondansetron 8mg tablets to support the recurring medical needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,148.15 contract is for the delivery of Ondansetron ODT 4 mg tablets over a period ending on July 18, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders...
- SPE2DB24D9802Indefinite Delivery Contract
- SPE2DB24D9802-SPE2DB25FJLDZDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,986.59 by the Defense Logistics Agency on September 8, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30. This delivery order, which carries no set-aside designation, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities worldwide. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its position as a small business to compete effectively in Department of Defense healthcare procurement markets. The company's extensive contract portfolio with the DLA demonstrates its capability to deliver diverse pharmaceutical products, including prescription medications, over-the-counter drugs, biologics, and medical consumables to military healthcare facilities across the nation. With an ultimate completion date of September 9, 2025, this delivery order exemplifies the routine pharmaceutical supply operations supporting DoD medical readiness requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 9/8/25 |